Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : University College London,
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
Phase II Study of Reduced Intensity Sibling Allogeneic Transplantation for Relapsed, Chemosensitive, PET Positive Hodgkin Lymphoma. Key words: Reduced intensity conditioning, Transplantation, Hodgkin lymphoma
To assess progression free survival following reduced intensity allogeneic transplantation in a relatively poor prognostic group of Hodgkin lymphoma patients, and allow comparison with historically ex...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
A phase II multicentre trial of CVP, rituximab and gemcitabine for the treatment of patients with newly diagnosed diffuse large b-cell lymphoma considered unsuitable for r-chop chemotherapy
The aim of the trial is evaluate the objective overall response rate of R-GCVP in patients with diffuse large B-cell non-Hodgkin’s lymphoma who cannot receive R-CHOP chemotherapy due to poor cardiac...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
Phase III, multicentre, randomised study of fludarabine/cyclophosphamide combination with or without Rituximab in patients with untreated mantle cell lymphoma
To evaluate the overall survival of patients treated with cyclophoshamide and fludarabine in comparison to rituximab, cyclophosphamide and fludarabine.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
Improving the needs of people with dementia in care homes
Background and study aims Dementia is a term given to a group of conditions that involve the gradual decline of a person’s mental faculties. People with dementia have difficulties with mental processe...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
University College London, Joint Research Office
MAJ Il y a 5 ans
MULTI CENTRE CONTROLLED STUDY ON THE IMPACT OF STEM CELL DONATION EITHER AFTER MOBILISATION WITH GRANULOCYTE COLONY STIMULATING FACTOR OR BONE MARROW HARVEST ON UNRELATED BONE MARROW DONORS
The aim of this study is two fold a) Detection of any genetic differences between bone marrow and PBSC unrelated donors, 3-5 years post donation and confirm or refute the observations of “long-term g...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
Transplantation of umbilical cord blood from unrelated donors in patients with haematological diseases using a myeloablative conditioning regimen
To assess the safety and efficacy of unrelated donor umbilical cord blood transplantation (UCBT) in a multi-institution UK setting where the use a myeloablative preparative regimen is indicated. The a...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
PiPS2: A study investigating predictions about how long patients with advanced cancer have left to live
Lay summary under review by external organisation
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai ouvert aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
XERXES: Examining the role of early neoadjuvant and synchronous Erbitux in pre-operative chemo-radiotherapy using Xeloda followed by excisional surgery. A phase I/II dose escalation study of intravenous erbitux (cetuximab) in combination with 5 day weekly oral Xeloda (capecitabine) and preoperative radiotherapy in rectal cancer
To evaluate the safety and toxicity of the combination of erbitux, capecitabine and radiotherapy. This will be determined through an assessment of the patient’s toxicity
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
Cardamon: a trial of carfilzomib, cyclophosmamide & dexamethasone with maintenance carfilzomib in patients with symptomatic multiple myeloma eligible for transplant to evaluate the benefit of upfront stem cell transplant
The purpose of the CARDAMON study is: • To determine the efficacy of the triple regimen Carfilzomib, Cyclophosphamide and Dexamethasone (CarCyDex) as induction in untreated patients with symptomatic...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
unknown
Plus d'informations
Femme et Homme Max 99 ans
University College London,
MAJ Il y a 5 ans
Belimumab after B Cell depletion therapy as a new treatment for patients with systemic lupus erythematosus (SLE)
Background and study aims Systemic lupus erythematosus (SLE) is a long-term (chronic) disease which causes widespread inflammation (swelling) in the body. SLE occurs when the immune system attacks the...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai ouvert aux inclusions
Plus d'informations
Précédent
2
3
4
5
6
7
8
9
10
11
Suivant